BetaSite: Completed therapy in a Phase III trial of 668 patients using a 0.1 percent and a 0.5 percent concentration of BetaSite

InSite Vision Inc. (INSV), Alameda, Calif. Product: BetaSite, INSV's DuraSite polymer eyedrop delivery system formulation of the beta-blocker levobunolol, which lowers intraocular pressure by reducing...